EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

Go back to EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies
(NASDAQ: EYEG) Delayed: 34.65 +0.17 (0.49%)
Previous Close $34.48    52 Week High $5.09 
Open $34.65    52 Week Low $1.11 
Day High $34.65    P/E N/A 
Day Low $34.65    EPS $0.00 
Volume 19